Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0016
+0.0009 (128.57%)
At close: Aug 14, 2026
Affymax Market Cap
Affymax has a market cap or net worth of $119.18 thousand as of August 14, 2026. Its market cap has increased by 100.00% in one year.
Market Cap
119.18K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.02
Stock Price
$0.00
ChartMarket Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 119.18K, a decrease of -99.98%. That is a compound annual growth rate of -34.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 119.18K | 100.00% |
| Dec 31, 2025 | 59.59K | - |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synairgen | 110.27K |
| Carisma Therapeutics | 92.06K |
| Sigyn Therapeutics | 76.29K |
| Vincerx Pharma | 66.48K |
| U.S. Stem Cell | 66.15K |
| PaxMedica | 63.14K |
| Scorpius Holdings | 61.14K |
| Nascent Biotech | 51.85K |